Correlation Between Salesforce and Xeris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Salesforce and Xeris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Xeris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Xeris Pharmaceuticals, you can compare the effects of market volatilities on Salesforce and Xeris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Xeris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Xeris Pharmaceuticals.
Diversification Opportunities for Salesforce and Xeris Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Salesforce and Xeris is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Xeris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeris Pharmaceuticals and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Xeris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeris Pharmaceuticals has no effect on the direction of Salesforce i.e., Salesforce and Xeris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Salesforce and Xeris Pharmaceuticals
Considering the 90-day investment horizon Salesforce is expected to generate 1.14 times less return on investment than Xeris Pharmaceuticals. But when comparing it to its historical volatility, Salesforce is 1.84 times less risky than Xeris Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Xeris Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 245.00 in Xeris Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 100.00 from holding Xeris Pharmaceuticals or generate 40.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Salesforce vs. Xeris Pharmaceuticals
Performance |
| Timeline |
| Salesforce |
| Xeris Pharmaceuticals |
Salesforce and Xeris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Xeris Pharmaceuticals
The main advantage of trading using opposite Salesforce and Xeris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Xeris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeris Pharmaceuticals will offset losses from the drop in Xeris Pharmaceuticals' long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Xeris Pharmaceuticals vs. Protalix Biotherapeutics | Xeris Pharmaceuticals vs. Seres Therapeutics | Xeris Pharmaceuticals vs. Cidara Therapeutics | Xeris Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |